Private Capital Advisors, Inc. Pfizer Inc Transaction History

Private Capital Advisors, Inc.

$913 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$25.89 - $29.73 $154,174 - $177,042	-5,955 Reduced 2.67%	216,710 $6.01 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $1.93 Million - $2.5 Million	-73,790 Reduced 24.89%	222,665 $6.41 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $313,423 - $366,360	-9,767 Reduced 3.19%	296,455 $9.06 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $6.11 Million - $7.06 Million	169,049 Added 123.24%	306,222 $11.2 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $1.44 Million - $1.88 Million	-36,648 Reduced 21.08%	137,173 $5.6 Million
Q4 2022 Feb 08, 2023	BUY	$41.75 - $54.5 $2,212 - $2,888	53 Added 0.03%	173,821 $8.91 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $4,376 - $5,342	-100 Reduced 0.06%	173,768 $7.6 Million
Q2 2022 Jul 21, 2022	SELL	$46.53 - $55.17 $232 - $275	-5 Reduced -0.0%	173,868 $9.12 Million
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $9,150 - $11,338	-200 Reduced 0.11%	173,873 $9 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $105,448 - $156,310	-2,552 Reduced 1.44%	174,073 $10.3 Million
Q3 2021 Oct 12, 2021	SELL	$39.25 - $50.42 $446,625 - $573,729	-11,379 Reduced 6.05%	176,625 $7.6 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $107,837 - $122,162	-3,003 Reduced 1.57%	188,004 $7.36 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $66,142 - $74,595	-1,975 Reduced 1.02%	191,007 $6.92 Million
Q4 2020 Jan 15, 2021	SELL	$33.47 - $42.56 $25,437 - $32,345	-760 Reduced 0.39%	192,982 $7.1 Million
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $635,000 - $745,000	20,000 Added 11.51%	193,742 $7.11 Million
Q2 2020 Jul 28, 2020	BUY	$30.12 - $36.54 $199,063 - $241,492	6,609 Added 3.95%	173,742 $5.68 Million
Q1 2020 Apr 15, 2020	SELL	$27.03 - $38.62 $62,277 - $88,980	-2,304 Reduced 1.36%	167,133 $5.46 Million
Q4 2019 Jan 09, 2020	SELL	$32.92 - $37.36 $8,230 - $9,340	-250 Reduced 0.15%	169,437 $6.64 Million
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $95,033 - $123,230	-2,925 Reduced 1.69%	169,687 $6.1 Million
Q1 2019 Apr 09, 2019	SELL	$37.5 - $41.2 $7,500 - $8,240	-200 Reduced 0.12%	172,612 $7.33 Million
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $263,626 - $319,762	-7,648 Reduced 4.24%	172,812 $7.62 Million
Q3 2018 Oct 12, 2018	BUY	$34.47 - $41.81 $290,030 - $351,789	8,414 Added 4.89%	180,460 $6.44 Million
Q2 2018 Jul 10, 2018	BUY	$32.98 - $35.16 $718,304 - $765,784	21,780 Added 14.49%	172,046 $6.24 Million
Q1 2018 Apr 18, 2018	SELL	$31.91 - $37.02 $95,730 - $111,060	-3,000 Reduced 1.96%	150,266 $5.33 Million
Q4 2017 Jan 12, 2018	SELL	$33.26 - $35.29 $904,472 - $959,676	-27,194 Reduced 15.07%	153,266 $5.55 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $5.59 Million - $6.16 Million	180,460	180,460 $6.44 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Advisors, Inc. with notifications on news.

Account